搜索筛选:
搜索耗时1.5385秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[会议论文] 作者：Xiaofei Wang,Fangfang Bai,Herbert Pang,Stephen George,
来源：上海交通大学 年份：2016
For time-to-event outcome of multiple treatment groups,the Kaplan-Meier estimator is often used to estimate survival functions of treatment groups and compute marginal treatment effects,such as differ...
[会议论文] 作者：Kai Dong,Herbert Pang,Tiejun Tong,Marc G.Genton,
来源：上海交通大学 年份：2016
High-throughput expression profiling techniques bring novel tools and also statis-tical challenges to genetic research....
Fibrobronchoscopic Cryorecanalization for Unresectable Secondary Malignant Tumors of the Trachea and
[会议论文] 作者：Qianli Ma,Bin Shi,Yanchu Tian,Deruo Liu,Xiaofei Wang,Herbert Pang,
来源：中国医师协会胸外科医师分会2015年会、第六届全国胸外科学术大会暨第八届浙江省胸部肿瘤论坛 年份：2015
Introduction: Most patients with secondary malignant tracheobronchial tumors have distressing symptoms due to major airway obstruction.However,they are always too frail for curative surgical resection...
Validation of progression-free survival as a surrogate endpoint for overall survival in malignant me
[会议论文] 作者：Herbert Pang,Lydia Hodgson,Xiaofei Wang,Stephen George,Xiaoyi Wang,Nate Foster,Daniel Sargent,Apar Kishor,
来源：第四届广州国际肿瘤学会议 年份：2015
To investigate whether progression-free survival(PFS)can be considered a surrogate endpoint for overall survival(OS)in malignant mesothelioma both at the pa...
Validation of progression-free survival as a surrogate endpoint for overall survival in malignant me
[会议论文] 作者：Herbert Pang,Xiaoyi Wang,Lydia Hodgson,Stephen George,Daniel Sargent,Nate Foster,Apar Kishor Ganti,Thomas,
来源：第四届广州国际肿瘤学会议 年份：2015
To investigate whether progression-free survival(PFS)can be considered a surrogate endpoint for overall survival(OS)in malignant mesothelioma both at the patient and trial level....
相关搜索：
